TP53 and osteosarcoma: It has been shown that 9.5% of young osteosarcoma cases (age < 30 years) carry a known pathogenic TP53 mutation (3.8%) or a rare exonic TP53 variant (5.7%) whereas none were identified in patients aged 30 years and older [10].